GlassScriptPhysician profile
Michaela A White
NPI 1902671712
$3,340.58
in general payments reported to CMS, 2019-2025
20 companies · $2,396 in 2025
The $2,396 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $945 · 2025: $2,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,340.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $903.50 | 2024-2025 | |
| Janssen Biotech, INC. | $580.67 | 2024-2025 | Tremfya |
| Incyte Corporation | $512.76 | 2024-2025 | Opzelura, Opzelura |
| Regeneron Healthcare Solutions, INC. | $260.17 | 2024-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $190.54 | 2025 | |
| Organon LLC | $167.32 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $111.04 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $109.57 | 2024-2025 | |
| Galderma Laboratories, L.P. | $93.89 | 2024-2025 | Nemluvio |
| Lilly USA, LLC | $91.52 | 2024-2025 | Taltz, Ebglyss |
| Pfizer INC. | $81.49 | 2024-2025 | |
| Ucb, INC. | $64.68 | 2025 | Bimzelx |
| Almirall LLC | $40.65 | 2025 | Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.48 | 2025 | Cabtreo |
| Botanix Sb INC | $21.45 | 2025 | Sofdra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $21.29 | 2024 | Zoryve |
| Leo Pharma INC. | $18.57 | 2025 | Adbry |
| Takeda Pharmaceuticals U.S.A., INC. | $18.01 | 2025 | Takhzyro |
| Lnhc, INC | $15.58 | 2025 | Zelsuvmi |
| Journey Medical Corporation | $15.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.